Company Overview and News


Add STAR
to your dashboard

Headline News

MSM - Cancellation Notice

2017-06-28 londonstockexchange
Listing and trading of the under mentioned security has been cancelled with effect from 27th June 2017.

Strides Shasun promoters raise Rs500 crore from KKR

2017-06-11 livemint
Strides Shasun will use the funding from KKR to restructure existing loans as well as expand some of the businesses

FIPB clears Claris Lifesciences’ bid to sell global generic injectables

2017-04-17 livemint
Claris Lifesciences has a total of 40 abbreviated new drug applications filed with the US FDA, of which 16 have been approved

Mylan Down on FDA Warning Letter to Manufacturing Facility

2017-04-12 zacks
Shares of Mylan, Inc. (MYL - Free Report) declined 2% after the company received a warning letter from the FDA for its manufacturing facility in India.

Newgen Positioned as a 'Leader' in ECM (Transactional Content Services) by an Independent Research Firm

2017-04-07 prnewswire
Newgen Software Inc., a leading global provider of Business Process Management (BPM), Enterprise Content Management (ECM), Customer Communication Management (CCM) and Case Management solutions, announced that it has been positioned as a 'Leader' in The Forrester Wave™: ECM Transactional Content Services, Q2 2017, authored by Cheryl McKinnon with Alex Cullen, Alex Kramer, and Sam Bartlett.

Mylan Reports Fourth Quarter and Full Year 2016 Results and Provides 2017 Guidance

2017-03-01 prnewswire
HERTFORDSHIRE, England and PITTSBURGH, March 1, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced its financial results for the quarter and year ended December 31, 2016 and provided 2017 guidance.

Stocks in news: Sun Pharma, Strides, JK Paper, Edelweiss

2016-12-23 moneycontrol
Sun Pharma | Maruti Suzuki | Redington | Sasken Communications | Voltamp Transformers | Strides Arcolab | JK Paper | Edelweiss Financial | Tata Metaliks | Hinduja Ventures | Suzlon Energy | Mahindra & Mahindra Financial and Hinduja Ventures are stocks, which are in the news today.

Vietnam blacklists 39 Indian drug firms

2016-11-25 biospectrumasia
It's fast, free and easy to sign in with Facebook, Google, or Yahoo. Be connected on your terms - we won't share anything without your permission

Mylan Reports Third Quarter 2016 Results

2016-11-09 prnewswire
HERTFORDSHIRE, England and PITTSBURGH, Nov. 9, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced its financial results for the quarter and nine months ended September 30, 2016.

Strides, Mylan agree to settle claims on Agila sale

2016-11-03 thehindubusinessline
Pharma major Strides Shasun and the US-based Mylan have agreed to settle regulatory and general claims on Agila transaction.

Strides, Mylan agree to settle claims on Agila sale

2016-11-03 moneycontrol
Strides had completed the sale of its Agila Specialties division to Mylan Inc for a total consideration of up to USD 1.75 billion in December 2013.

Strides, Mylan to settle regulatory and general claims on Agila deal

2016-11-03 livemint
As per the settlement, Strides will get about $30 million from regulatory escrow after it makes the payment to Mylan on acquisition of injectables unit Agila Specialties

Strides Arcolab Ltd's Q2FY17 consolidated net profit rises 106.73% yoy to Rs.74.1 crore : In-line with Estimates

2016-10-28 indiainfoline
Strides Arcolab Ltd's Q2FY17 consolidated net profit rises 106.73% yoy to Rs.74.1 crore : In-line with Estimates

Panel to investigate pharma firms red-listed by Vietnam

2016-09-04 livemint
CDSCO plans to rope in state drug control organizations to look into the issues raised by Vietnam over the quality of drugs from India

Strides Shasun gains amid high volumes after receiving USFDA approval for drug

2016-08-24 indiainfoline
Strides Shasun gained 0.98% to Rs 966.95 at 14:25 IST on BSE after the company announced that it has received approval from the United States Food & Drug Administration for Ranitidine Tablets.

Strides Shasun rises 4% on EIR from USFDA for Bangalore plant

2016-06-07 moneycontrol
"Oral dosage forms manufacturing site in Bangalore has received the establishment inspection report (EIR) from the US Food & Drug Administration, thereby confirming the closure of the inspection. The facility continues to be US FDA Approved," the pharma company said in its filing.

Pre-markets: Sensex, Nifty may open on flat-to-cautious note; Bank of Baroda in focus today

2016-05-16 financialexpress
9.55 am: There will lots of important earnings announcements too, to keep the markets in action. Strides Arcolab, Shasun, JK Tyre, Petronet LNG, NBCC, TRF, Mangalam Cement, Tata Coffee, BF Utilities and Gujarat Fluorochemicals, among others are scheduled to announce their results today.

The Top Dividend Paying ETFs and Stocks

2016-01-02 seekingalpha
I like the idea of letting money work for me on its own. One way to do that is buying equities that generate dividends. Last year, about 10% of our gains were from dividends, capital gains, and intere

Merck's combo HCV drug candidate shows 95% cure rate in IV drug abusers

2015-11-15 seekingalpha
Results from a Phase 3 clinical trial, C-EDGE CO-STAR, show a 95% (n=189/198) cure rate in HCV-1, -4 or -6-positive patients who inject drugs and are receiving opioid agonist therapy for their ad

Merck Announces Presentation of Phase 3 Results of Investigational Elbasvir/Grazoprevir in People with Chronic Hepatitis C Genotypes 1, 4 or 6 Infection Who Inject Drugs and Are on Opioid Agonist Therapy

2015-11-15 finance.yahoo
Merck , known as MSD outside the United States and Canada, today announced the presentation of results from the company’s Phase 3 C-EDGE CO-STAR clinical trial evaluating the efficacy and safety of the investigational once-daily tablet elbasvir/grazoprevir1 in patients with chronic hepatitis C virus genotypes 1, 4 or 6 infection who inject drugs and are receiving opioid agonist therapy .

Typical Millennials Should Allocate At Least 25% Of Their Portfolio To This Specific Asset Class

2015-11-04 seekingalpha
The typical millennial profile (post-college graduation) has human capital as their only asset, but is also effectively short both bonds (student debt) and residential real estate (renters).Given most

Boosted buyback at iStar pleases sell-side bull

2015-09-22 seekingalpha
The faster pace of buybacks for iStar Financial (NYSE:STAR) is especially notable given CEO Jay Sugarman earlier this year was dismissive of the notion that repurchases represented the company's best

iStar tops off repurchase program

2015-09-21 seekingalpha
The buyback program had $28.5M of remaining availability as of June 30, and recent purchases have brought that amount down to about $10M. The board authorizes an increase to $50M.At today's close of $

Greetings From Asbury Park where iStar Financial is leading redevelopment of waterfront

2015-08-19 seekingalpha
The multi-billion dollar redevelopment plan for a 1.25 mile stretch of Asbury Park waterfront involves more than 20 individual projects, and iStar (NYSE:STAR) CEO Jay Sugarman has assembled an "al

BTIG: Investor presentation next week is a big one for iStar Financial

2015-06-05 seekingalpha
Why the gap between iStar's (STAR -0.7%) asset value/business prospects and the share price? First, says Mark Palmer, is the stock doesn't fit neatly into a single coverage category, i.e. it's a REIT